000 | 01739 a2200469 4500 | ||
---|---|---|---|
005 | 20250516221733.0 | ||
264 | 0 | _c20151028 | |
008 | 201510s 0 0 eng d | ||
022 | _a2045-2322 | ||
024 | 7 |
_a10.1038/srep05511 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChiang, Kun-Chun | |
245 | 0 | 0 |
_aCisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways. _h[electronic resource] |
260 |
_bScientific reports _cJul 2014 |
||
300 |
_a5511 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmediate-Early Proteins _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
650 | 0 | 4 |
_aTumor Suppressor Proteins _xmetabolism |
650 | 0 | 4 | _aNF-kappaB-Inducing Kinase |
700 | 1 | _aTsui, Ke-Hung | |
700 | 1 | _aChung, Li-Chuan | |
700 | 1 | _aYeh, Chun-Nan | |
700 | 1 | _aFeng, Tsui-Hsia | |
700 | 1 | _aChen, Wen-Tsung | |
700 | 1 | _aChang, Phei-Lang | |
700 | 1 | _aChiang, Hou-Yu | |
700 | 1 | _aJuang, Horng-Heng | |
773 | 0 |
_tScientific reports _gvol. 4 _gp. 5511 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep05511 _zAvailable from publisher's website |
999 |
_c23968896 _d23968896 |